Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
Pheezee is designed to assess musculoskeletal and neuromuscular health.
Nous-209 has been developed using the Nouscom's viral vector platform
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
New agreement applies to the polymers of the Medical Care series portfolio
Subscribe To Our Newsletter & Stay Updated
